Serum 17β-Estradiol (E2) concentrations fluctuate dynamically across the female menstrual cycle, spanning from 30 to 100 pg/mL in the early follicular phase to a pre-ovulatory peak of 200 to 450+ pg/mL and settling at 60 to 250 pg/mL during the luteal phase. In untreated postmenopausal women, baseline levels drop below < 10 to 20 pg/mL, whereas optimal clinical targets for transdermal hormone therapy aim for 50 to 100 pg/mL to preserve bone density and neurocognitive health.
When interpreting an Estradiol (E2) blood test result, seeing a wide laboratory reference range spanning anywhere from 30 to 450 pg/mL frequently causes confusion.
Unlike static metabolic biomarkers like fasting glucose or creatinine, circulating estradiol in women of reproductive age fluctuates continuously based on follicular development and the phase of the menstrual cycle.
Consequently, evaluating an estradiol lab result requires knowing the exact cycle day of the blood draw and matching it to specific physiological milestones.
What are the normal estradiol ranges across the follicular, ovulatory, luteal, and postmenopausal phases, what causes abnormally high or low levels, and what is the optimal target for hormone therapy?
Normal Estradiol Levels Across Menstrual Cycle Phases#
[THE 28-DAY MENSTRUAL CYCLE ESTRADIOL TRAJECTORY]
Concentration
(pg/mL)
500 ── ▲ (Pre-Ovulatory Peak: 200–450+)
400 ── ╱ ╲
300 ── ╱ ╲ ▲ (Luteal Peak: 60–250)
200 ── ╱ ╲ ╱ ╲
100 ── ─────── (Follicular: 30–100) ────╱ ╲──────────╱ ╲────────
0 ──┴──────────┴──────────┴──────────┴──────────┴──────────┴──────────┴──
Day 1 Day 5 Day 10 Day 14 Day 18 Day 21 Day 28
(Menses) (Early) (Late) (Ovulation) (Early Lut) (Mid-Lut) (Menses)
| Menstrual Cycle Phase | Approximate Cycle Days | Standard Reference Range (pg/mL) | Standard SI Units (pmol/L) | Biological Role & Significance |
|---|---|---|---|---|
| Early Follicular (Baseline) | Days 1 to 5 | 30 to 100 pg/mL | 110 to 367 pmol/L | Low baseline allows pituitary to release FSH to recruit a new cohort of ovarian follicles. |
| Mid-to-Late Follicular | Days 6 to 11 | 100 to 250 pg/mL | 367 to 918 pmol/L | Maturing dominant Graafian follicle secretes exponential estradiol to rebuild the endometrial lining. |
| Pre-Ovulatory Surge | Days 12 to 14 | 200 to 450+ pg/mL | 734 to 1,650+ pmol/L | Sustained high E2 (> 200 pg/mL for 36+ hrs) triggers the Luteinizing Hormone (LH) surge that causes ovulation. |
| Mid-Luteal Phase | Days 19 to 23 | 60 to 250 pg/mL | 220 to 918 pmol/L | The Corpus Luteum co-secretes estradiol alongside progesterone to mature the uterine lining for implantation. |
| Untreated Postmenopause | N/A | < 10 to 20 pg/mL | < 37 to 73 pmol/L | Permanent cessation of ovarian follicular activity; minor residual estrone from fat aromatization. |
| Transdermal MHT Target | N/A | 50 to 100 pg/mL | 184 to 367 pmol/L | Therapeutic window to eliminate hot flashes, prevent bone loss, and preserve cardiovascular health. |
Causes of Abnormally High Estradiol (> 450 pg/mL)#
Outside of the normal mid-cycle ovulatory peak, persistently elevated estradiol can indicate:
- Ovarian Hyperstimulation / Functional Cysts: Persistent follicular cysts continuing to synthesize estrogen.
- Obesity & Peripheral Aromatization: Adipose tissue expresses the enzyme aromatase (CYP19A1), which converts circulating androgens (DHEA and androstenedione) into estrone and estradiol.
- Severe Liver Impairment / Cirrhosis: The liver is the primary organ responsible for conjugating and clearing estrogens (via 2-hydroxylation and sulfation); severe hepatic dysfunction allows estradiol to recirculate.
- Granulosa Cell Tumors: Rare ovarian stromal neoplasms that hyper-secrete massive quantities of estradiol.
Causes of Abnormally Low Estradiol (< 30 pg/mL)#
In women of reproductive age (under age 45), low circulating estradiol warrants investigation:
[LOW ESTRADIOL (< 30 pg/mL) IN WOMEN OF REPRODUCTIVE AGE]
│
┌───────────────────────┴───────────────────────┐
▼ ▼
[HIGH PITUITARY FSH (> 25 mIU/mL)] [LOW / NORMAL PITUITARY FSH (< 5 mIU/mL)]
- PRIMARY OVARIAN FAILURE - HYPOTHALAMIC / PITUITARY FAILURE
- Causes: - Causes:
* Premature Ovarian Insufficiency (POI) * Functional Hypothalamic Amenorrhea (FHA)
* Natural Menopause * Relative Energy Deficiency in Sport (RED-S)
* Autoimmune Oophoritis * Severe Caloric Restriction / Low Body Fat
* Chemotherapy / Radiation Damage * High Systemic Stress / Hyperprolactinemia
Testing Technology: Direct Immunoassay vs. LC-MS/MS#
When testing postmenopausal women, men, or children:
- Standard Direct Immunoassays: Often lose precision at low concentrations (< 20 pg/mL) due to cross-reactivity with other steroid metabolites.
- Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS): The gold-standard analytical method that accurately measures ultra-low estradiol down to 1.0 pg/mL.
Drawing estradiol on Cycle Day 3 paired with FSH provides the most accurate assessment of ovarian reserve. A Day 3 estradiol > 80 pg/mL indicates advanced follicular recruitment that falsely suppresses FSH into a deceptive "normal" range.
To explore how the pituitary hormone FSH regulates ovulation and menopause, read Follicle-Stimulating Hormone (FSH) Levels: Fertility & Menopause.
Scientific References & Clinical Practice Guidelines#
- American College of Obstetricians and Gynecologists (ACOG). Clinical Consensus No. 3: General Approaches to Medical Management of Menstrual Suppression. Obstet Gynecol. 2022;140(3):528-541.
- The NAMS 2022 Hormone Therapy Position Statement Advisory Panel. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause. 2022;29(7):767-794. doi:10.1097/GME.0000000000002028.
- Stanczyk FZ, Clarke NJ. Advantages and challenges of mass spectrometry assays for steroid hormones. J Steroid Biochem Mol Biol. 2010;121(3-5):491-495. doi:10.1016/j.jsbmb.2010.05.001.
- Harlow SD, Gass M, Hall JE, et al. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. J Clin Endocrinol Metab. 2012;97(4):1159-1168. doi:10.1210/jc.2011-3362.
- Practice Committee of the American Society for Reproductive Medicine. Testing and interpreting measures of ovarian reserve: a committee opinion. Fertil Steril. 2020;114(6):1151-1157. doi:10.1016/j.fertnstert.2020.09.134.
Track Your Estradiol & Hormone Tests with Meridian#
Monitoring your laboratory blood biomarkers over time gives you objective validation that your diet, exercise, and lifestyle habits are keeping your metabolic health and glucose tolerance in optimal ranges.
Meridian is an offline personal health vault for iPhone designed to give you complete ownership of your medical diagnostic data.
- Instant Lab Report Extraction: Take a photo or upload a PDF of your Comprehensive Hormone Panels (Estradiol E2, Progesterone, FSH, LH, AMH, and Total/Free Testosterone) from Quest, Labcorp, or your clinic. Meridian extracts all biomarkers on-device using Apple VisionKit.
- Longitudinal Menstrual & Menopause Tracking: Track your cycle-matched estradiol fluctuations and menopausal hormone therapy targets over years with total privacy.
- 100% On-Device & Private: Protected by hardware AES-256 encryption and FaceID. Zero cloud servers. Zero data tracking.
Take control of your hormonal health and medical privacy today. Download Meridian on the App Store and keep your diagnostic records organized, private, and secure.